Genetics Generation Advancement Corp. 4160.TWO Stock
Genetics Generation Advancement Corp. Price Chart
Genetics Generation Advancement Corp. 4160.TWO Financial and Trading Overview
| Genetics Generation Advancement Corp. stock price | 75.4 TWD |
| Previous Close | 37.35 TWD |
| Open | 37.4 TWD |
| Bid | 37.9 TWD x 0 |
| Ask | 38 TWD x 0 |
| Day's Range | 37.4 - 38.05 TWD |
| 52 Week Range | 23 - 54.9 TWD |
| Volume | 70.21K TWD |
| Avg. Volume | 311.02K TWD |
| Market Cap | 920.17M TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 43.62069 |
| EPS (TTM) | 1.38 TWD |
| Forward Dividend & Yield | 0.29 (0.75%) |
| Ex-Dividend Date | September 5, 2022 |
| 1y Target Est | N/A |
4160.TWO Valuation Measures
| Enterprise Value | 905.63M TWD |
| Trailing P/E | 43.62069 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.6482904 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Genetics Generation Advancement Corp. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 49.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 54.9 TWD |
| 52 Week Low | 23 TWD |
| 50-Day Moving Average | 39.11 TWD |
| 200-Day Moving Average | 29.5 TWD |
4160.TWO Share Statistics
| Avg. Volume (3 month) | 311.02K TWD |
| Avg. Daily Volume (10-Days) | 106.1K TWD |
| Shares Outstanding | 24.25M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 40.17% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.3163 |
| Last Split Factor | 1.035:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 22.59 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 226.44M TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.87 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 14.33 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Genetics Generation Advancement Corp.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 28, Xinhu 1st Road |
| ZIP | 11494 |
| Phone | 886 2 2795 1777 |
| Website | https://www.gga.asia |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan, Asia, Europe, and the Americas. The company offers pre-implantation stage, prenatal stage, newborn medical examination, health management, reproductive medicine, obstetrics and gynecology, neonatology and pediatrics, allergy/immunology/rheumatology, gastroenterology and hepatology, oncology, cardiology, and medical research testing services, as well as counseling services for clinicians and patients to identify genetic risks, genetic testing options, interpret the implications of the test results, and help patients make informed healthcare decisions. It also provides bioinformatics and computational life sciences, materials sciences, laboratory informatics, and enterprise quality management system services. The company was formerly known as Genesis Genetics Asia Corp. and changed its name to Genetics Generation Advancement Corp. in February 2016. Genetics Generation Advancement Corp. was founded in 2008 and is based in Taipei, Taiwan.
Q&A For Genetics Generation Advancement Corp. Stock
What is a current 4160.TWO stock price?
Genetics Generation Advancement Corp. 4160.TWO stock price today per share is 75.4 TWD.
How to purchase Genetics Generation Advancement Corp. stock?
You can buy 4160.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genetics Generation Advancement Corp.?
The stock symbol or ticker of Genetics Generation Advancement Corp. is 4160.TWO.
Which industry does the Genetics Generation Advancement Corp. company belong to?
The Genetics Generation Advancement Corp. industry is Diagnostics & Research.
How many shares does Genetics Generation Advancement Corp. have in circulation?
The max supply of Genetics Generation Advancement Corp. shares is 25.4M.
What is Genetics Generation Advancement Corp. Price to Earnings Ratio (PE Ratio)?
Genetics Generation Advancement Corp. PE Ratio is 54.63768400 now.
What was Genetics Generation Advancement Corp. earnings per share over the trailing 12 months (TTM)?
Genetics Generation Advancement Corp. EPS is 1.38 TWD over the trailing 12 months.
Which sector does the Genetics Generation Advancement Corp. company belong to?
The Genetics Generation Advancement Corp. sector is Healthcare.